SlideShare une entreprise Scribd logo
1  sur  40
Neurochemistry III: Acetylcholine

       Brian J. Piper, Ph.D.
Objectives
• Synthesis
• Breakdown
• Receptors
  – nACh
  – M1 to M5
• Neuroanatomy
• Alzheimer’s Disease
History


1875-1968
  • Sir Henry Dale (Dale’s law) describes 1873-1961
    neuron communication as chemical
    involving Acectylcholine (ACh) in 1914
  • Otto Loewi discovers ACh can inhibit the
    rate of heartbeat in frogs
  • Nobel Prize 1936
6.1 Synthesis of acetylcholine (ACh) by choline acetyltransferase




        • Choline: essential nutrient
        • Acetyl-CoA: acetyl co-enzyme A
        • ChAT: choline acetyl (COCH3) transferase




http://lpi.oregonstate.edu/infocenter/othernuts/choline/
Synthesis of acetylcholine (ACh) by choline acetyltransferase




        • Choline: essential nutrient
        • Acetyl-CoA: acetyl co-enzyme A
        • ChAT: choline acetyl (COCH3) transferase




http://lpi.oregonstate.edu/infocenter/othernuts/choline/
Choline During Development

    • Choline supplementation shows preclinical
      benefits against age related cognitive
      decline and against FAS.
    • Are there emotional benefits (open-field & FST)




                                 Glenn et al. (2012) Brain Research
Acetylcholine Production



 • VAChT: vesicular Acetylcholine transporter
   packages ACh
 • Vesamicol: research drug that blocks VAChT




Stahl (2001). p. 468
Acetylcholine Inactivation



     •   AChE: acetylcholinesterase, breaks down Ach
     •   ChT: Choline Transporter, recycles choline into presynaptic terminal




 Stahl (2001). p. 469.
6.9 Structure of the nicotinic ACh receptor

•   Ionotropic
•   Requires 2 ACh
•   Activated by nicotine
•   Blocked by curare
6.4 Myasthenia gravis, an autoimmune disorder




                                                   Prevalence: 10/million
                                                   Tx: AChE inhibitors,




  Upto 1:30:
  http://www.youtube.com/watch?v=XdpW5RMp-T0&feature=related
Muscarinic Acetylcholine Receptors




• Metabotropic
• M1, M2, M3, M4, M5
                                     Amanita muscaria
• Trace amounts of muscarine
  isolated from Amanita muscaria
  in 1869
• Found in brain & heart
• Antagonist: Atropa Belladonna         Inocybe rimosa
  (atropine)
Preference?
Preference?
6.7 Anatomy of cholinergic pathways in the brain




• Nucleas basilis: connections to forebrain,
  important for cognition
• Caudate-Putamen: important for motor
  function
Lesson from Lesion Studies




    • 192 IgG-Saporin: destroys ACh neurons
    • Functional Deficits not shown until >70%
      depletions
6.6 Cholinergic synapses in the parasympathetic and sympathetic branches of the ANS
Botulism

• Infection causes reduced ACh and release
• Infants are particularly susceptible
Botulinum Toxin A

• Botox is FDA approved for cosmetic
  purposes
• Also used for excessive sweating
Summary
Aloysius ”Alois” Alzheimer
• German psychiatrist
• Described symptoms + pathology
                                                                       1864-1913
    – Neuronal loss
    – Plaques
    – Tangles
• Presentation to SW German
  Psychiatrist meeting ignored but
  Emil Kraeplin
Cipriani et al. (2011) Neurological Sciences, 32(2), 275-279. Auguste Deter, 1851-1906
1st, but possibly, atypical case
Healthy   Alzheimer’s
Disease
AD, external aspect
AD, coronal cross section
Amyloid Plaque




• Amyloid Beta Peptide:
  40/42 amino acids
• Amyloid Plaque: clusters
  of Beta amyloid +
• Neurofibrillary tangles
Test of Neurocognitive Function




     • Mini-Mental Status Exam (MMSE)
          – Where are we in?
          – Count backwards by 7 starting with 100.
          – Remember 3 words.
     • Spatial Learning & Memory
     • Executive function



Folstein, Folstein, & McHugh (1975). J Psychiatric Research, 12, 189-198.
Alzheimer’s Vaccine?

• Immunization against
  AB42 produced
  antibodies
• Brain versus
  Behavior




Holmes et al. (2008) Lancet, 372, 216-223.
Executive Function Test: Trail Making Test: Part A
Trail Making Test: Part B
Executive Function Test 2: Tower of London
Tower of London: Difficult Trial
Genetic Risk Factors



• Apolipoprotein E:      Isoform 112       158
  – Chromosome 19
                         E2     Cysteine   Cysteine
  – 299 amino acids
  – E3 > E2 > E4
                         E3     Cysteine   Arginine



                         E4     Agrinine   Agrinine
ApoE &
    Alzheimer’s
    Disease




Corder et al. (1993). Science, 261, 921-3.
Hippocampus, CA1, tau IHC
Higher magnification
Current Alzheimer’s Treatments

• Alzheimer’s does involve
  neurodegeneration of cholinergic neurons
• Acetylcholinesterase inhibitors (tacrine)
  have resulted in only modest/brief benefits
Summary

                              Acetylcholine
Synthetic Enzymes
Inactivating Enzymes
Vesicular Transporter
Membrane Transporter
Where in brain (somas)?
Ionotropic Receptor(s)
Metabotropic Receptor(s)
Agonist(s)
Antagonist(s)
Disease(s)
Self-Test

                               Acetylcholine
Synthetic Enzymes              Choline Acetyltransferase
Inactivating Enzymes           Acetylcholinesterase
Vesicular Transporter          VAChT
Membrane Transporter           Choline Transporter
Where in brain (somas)?        Nucleus basilis, striatum
Ionotropic Receptor(s)         nACh
Metabotropic Receptor(s)       M1 – M5
Agonist(s)                     Nicotine, Muscarine
Antagonist(s)                  Atropine
Disease(s)                     Myasthenia Gravis, Alzheimer’s?
Neuropharmacology: Acetylcholine & Alzheimer's

Contenu connexe

Tendances

Cellular and biochemical mediators of Inflammation.pptx
Cellular and biochemical mediators of Inflammation.pptxCellular and biochemical mediators of Inflammation.pptx
Cellular and biochemical mediators of Inflammation.pptxdhanushyagopal
 
Non adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmittersNon adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmittersRahulvaish13
 
Acetylcholine
AcetylcholineAcetylcholine
AcetylcholineWali Khan
 
Genetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptorsGenetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptorsSachinGulia12
 
Serotonin and its role in psychiatry.pptx
Serotonin and its role in psychiatry.pptxSerotonin and its role in psychiatry.pptx
Serotonin and its role in psychiatry.pptxAdityaAgrawal238
 
Genome organization and gene expression and its regulation
Genome organization and gene expression and its regulationGenome organization and gene expression and its regulation
Genome organization and gene expression and its regulationabhishek soni
 
Aminoacid neurotransimitter
Aminoacid neurotransimitterAminoacid neurotransimitter
Aminoacid neurotransimitterVln Sekhar
 
Neurodegenerative disorders
Neurodegenerative disordersNeurodegenerative disorders
Neurodegenerative disordersMohammed Yousuf
 
Molecular Mechanisms of Neurodegeneration: Neurodegenerative Disorders Webin...
Molecular Mechanisms of Neurodegeneration:  Neurodegenerative Disorders Webin...Molecular Mechanisms of Neurodegeneration:  Neurodegenerative Disorders Webin...
Molecular Mechanisms of Neurodegeneration: Neurodegenerative Disorders Webin...QIAGEN
 
Neurodegenerative diseases ppt
Neurodegenerative diseases ppt Neurodegenerative diseases ppt
Neurodegenerative diseases ppt Tukai Kulkarni
 
NEURODEGENERATIVE DISORDERS
NEURODEGENERATIVE DISORDERSNEURODEGENERATIVE DISORDERS
NEURODEGENERATIVE DISORDERSMariya Raju
 
Serotonin pharmacology
Serotonin  pharmacologySerotonin  pharmacology
Serotonin pharmacologyAliLaith5230
 
serotonin/neurotransmitter
serotonin/neurotransmitterserotonin/neurotransmitter
serotonin/neurotransmitterLollan Daran
 
Neurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptxNeurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptxSIRAJUDDIN MOLLA
 
GABA, glutamate receptors and their modulation
GABA, glutamate receptors and their modulationGABA, glutamate receptors and their modulation
GABA, glutamate receptors and their modulationDrSahilKumar
 

Tendances (20)

Cellular and biochemical mediators of Inflammation.pptx
Cellular and biochemical mediators of Inflammation.pptxCellular and biochemical mediators of Inflammation.pptx
Cellular and biochemical mediators of Inflammation.pptx
 
Non adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmittersNon adrenergic, non-cholinergic (nanc) transmitters
Non adrenergic, non-cholinergic (nanc) transmitters
 
Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 
Neurotransmitters
NeurotransmittersNeurotransmitters
Neurotransmitters
 
Genetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptorsGenetic variation in G protein coupled receptors
Genetic variation in G protein coupled receptors
 
Serotonin and its role in psychiatry.pptx
Serotonin and its role in psychiatry.pptxSerotonin and its role in psychiatry.pptx
Serotonin and its role in psychiatry.pptx
 
Genome organization and gene expression and its regulation
Genome organization and gene expression and its regulationGenome organization and gene expression and its regulation
Genome organization and gene expression and its regulation
 
Aminoacid neurotransimitter
Aminoacid neurotransimitterAminoacid neurotransimitter
Aminoacid neurotransimitter
 
Neurodegenerative disorders
Neurodegenerative disordersNeurodegenerative disorders
Neurodegenerative disorders
 
Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 
Molecular Mechanisms of Neurodegeneration: Neurodegenerative Disorders Webin...
Molecular Mechanisms of Neurodegeneration:  Neurodegenerative Disorders Webin...Molecular Mechanisms of Neurodegeneration:  Neurodegenerative Disorders Webin...
Molecular Mechanisms of Neurodegeneration: Neurodegenerative Disorders Webin...
 
Neurodegenerative diseases ppt
Neurodegenerative diseases ppt Neurodegenerative diseases ppt
Neurodegenerative diseases ppt
 
Serotonin
SerotoninSerotonin
Serotonin
 
NEURODEGENERATIVE DISORDERS
NEURODEGENERATIVE DISORDERSNEURODEGENERATIVE DISORDERS
NEURODEGENERATIVE DISORDERS
 
Neuropeptides
NeuropeptidesNeuropeptides
Neuropeptides
 
Serotonin pharmacology
Serotonin  pharmacologySerotonin  pharmacology
Serotonin pharmacology
 
serotonin/neurotransmitter
serotonin/neurotransmitterserotonin/neurotransmitter
serotonin/neurotransmitter
 
Neurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptxNeurotransmitters/General aspect and steps involved in neurotransmission.pptx
Neurotransmitters/General aspect and steps involved in neurotransmission.pptx
 
GABA, glutamate receptors and their modulation
GABA, glutamate receptors and their modulationGABA, glutamate receptors and their modulation
GABA, glutamate receptors and their modulation
 
Neuropeptide y
Neuropeptide yNeuropeptide y
Neuropeptide y
 

Similaire à Neuropharmacology: Acetylcholine & Alzheimer's

Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...
Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...
Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...Luke Lightning
 
Cholinergic neurotransmission (1)
Cholinergic neurotransmission (1)Cholinergic neurotransmission (1)
Cholinergic neurotransmission (1)Siraj Ansari
 
Chapter 3 cholinergic agents by Somashekhar m metri
Chapter 3 cholinergic agents by Somashekhar m metriChapter 3 cholinergic agents by Somashekhar m metri
Chapter 3 cholinergic agents by Somashekhar m metrisomashekharmetri1
 
4 ANS Intro + Cholinergics -41 ff(1).ppt
4 ANS Intro + Cholinergics  -41 ff(1).ppt4 ANS Intro + Cholinergics  -41 ff(1).ppt
4 ANS Intro + Cholinergics -41 ff(1).pptAbdelrhman abooda
 
Acetylcholineppt1070
Acetylcholineppt1070Acetylcholineppt1070
Acetylcholineppt1070Zeeshan Ahmad
 
Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017http://neigrihms.gov.in/
 
Drug affecting parasympathetic system
Drug affecting parasympathetic  systemDrug affecting parasympathetic  system
Drug affecting parasympathetic systemawad Dr.awad
 
Neuromuscular junction & autonomic ganglia
Neuromuscular junction & autonomic gangliaNeuromuscular junction & autonomic ganglia
Neuromuscular junction & autonomic gangliaBrian Piper
 
CHOLINERGIC TRANSMISSION bph 23.pptx
CHOLINERGIC  TRANSMISSION bph 23.pptxCHOLINERGIC  TRANSMISSION bph 23.pptx
CHOLINERGIC TRANSMISSION bph 23.pptxPharmTecM
 
Cholinergic system Class I
Cholinergic system Class ICholinergic system Class I
Cholinergic system Class IRathnakar U P
 

Similaire à Neuropharmacology: Acetylcholine & Alzheimer's (20)

Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 
Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...
Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...
Butyrylcholinesterase Overview: Substrates Inhibitors Structure Mechanism The...
 
Screening models of alzheimer disease
Screening models of alzheimer diseaseScreening models of alzheimer disease
Screening models of alzheimer disease
 
Ans (parasympathetic)
Ans (parasympathetic)Ans (parasympathetic)
Ans (parasympathetic)
 
Cholinergic neurotransmission (1)
Cholinergic neurotransmission (1)Cholinergic neurotransmission (1)
Cholinergic neurotransmission (1)
 
Prezentare
PrezentarePrezentare
Prezentare
 
Ans latest
Ans latestAns latest
Ans latest
 
Chapter 3 cholinergic agents by Somashekhar m metri
Chapter 3 cholinergic agents by Somashekhar m metriChapter 3 cholinergic agents by Somashekhar m metri
Chapter 3 cholinergic agents by Somashekhar m metri
 
4 ANS Intro + Cholinergics -41 ff(1).ppt
4 ANS Intro + Cholinergics  -41 ff(1).ppt4 ANS Intro + Cholinergics  -41 ff(1).ppt
4 ANS Intro + Cholinergics -41 ff(1).ppt
 
Cholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugsCholinergic and Anticholinesterase drugs
Cholinergic and Anticholinesterase drugs
 
Parasympathomimetics
ParasympathomimeticsParasympathomimetics
Parasympathomimetics
 
Acetylcholineppt1070
Acetylcholineppt1070Acetylcholineppt1070
Acetylcholineppt1070
 
Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017Cholinergic Pharmacology and Cholinergic Drugs 2017
Cholinergic Pharmacology and Cholinergic Drugs 2017
 
Drug affecting parasympathetic system
Drug affecting parasympathetic  systemDrug affecting parasympathetic  system
Drug affecting parasympathetic system
 
Alzheimer disease
Alzheimer diseaseAlzheimer disease
Alzheimer disease
 
Neuromuscular junction & autonomic ganglia
Neuromuscular junction & autonomic gangliaNeuromuscular junction & autonomic ganglia
Neuromuscular junction & autonomic ganglia
 
Acetylcholine
AcetylcholineAcetylcholine
Acetylcholine
 
AN_A&D2016
AN_A&D2016AN_A&D2016
AN_A&D2016
 
CHOLINERGIC TRANSMISSION bph 23.pptx
CHOLINERGIC  TRANSMISSION bph 23.pptxCHOLINERGIC  TRANSMISSION bph 23.pptx
CHOLINERGIC TRANSMISSION bph 23.pptx
 
Cholinergic system Class I
Cholinergic system Class ICholinergic system Class I
Cholinergic system Class I
 

Plus de Brian Piper

Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Brian Piper
 
Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Brian Piper
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettesBrian Piper
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Brian Piper
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Brian Piper
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IIBrian Piper
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part IBrian Piper
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for BipolarBrian Piper
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDBrian Piper
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADBrian Piper
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part IIBrian Piper
 
Antipsychotics I
Antipsychotics IAntipsychotics I
Antipsychotics IBrian Piper
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNSBrian Piper
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part IIBrian Piper
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part IBrian Piper
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part IIBrian Piper
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part IBrian Piper
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain InjuryBrian Piper
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromeBrian Piper
 

Plus de Brian Piper (20)

Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
Current recreational drugs: RX462 Drug Abuse & Society, Spring 2015 Class pre...
 
Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014Drug Abuse & Society (RX 462) Presentations-Spring 2014
Drug Abuse & Society (RX 462) Presentations-Spring 2014
 
electronic cigarettes
electronic cigaretteselectronic cigarettes
electronic cigarettes
 
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
Examination of Sexually Dimorphic Behavior on the Novel-Image Novel-Location ...
 
Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013Drug abuse and society drug presentations: Spring 2013
Drug abuse and society drug presentations: Spring 2013
 
Sedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part IISedative & Hypnotic Drugs Part II
Sedative & Hypnotic Drugs Part II
 
Sedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part ISedative & Hypnotic Agents Part I
Sedative & Hypnotic Agents Part I
 
Agents for Bipolar
Agents for BipolarAgents for Bipolar
Agents for Bipolar
 
Psychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSDPsychopharmacology of Anxiety: Part II OCD & PTSD
Psychopharmacology of Anxiety: Part II OCD & PTSD
 
Psychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SADPsychopharmacology of Anxiety Disorders I: GAD & SAD
Psychopharmacology of Anxiety Disorders I: GAD & SAD
 
Antipsychotics Part II
Antipsychotics Part IIAntipsychotics Part II
Antipsychotics Part II
 
Antipsychotics I
Antipsychotics IAntipsychotics I
Antipsychotics I
 
Anti Inflammation agents for CNS
Anti Inflammation agents for CNSAnti Inflammation agents for CNS
Anti Inflammation agents for CNS
 
Antidepressants Part II
Antidepressants Part IIAntidepressants Part II
Antidepressants Part II
 
Antidepressants Part I
Antidepressants Part IAntidepressants Part I
Antidepressants Part I
 
Anticonvulsants Part II
Anticonvulsants Part IIAnticonvulsants Part II
Anticonvulsants Part II
 
Anticonvulsants Part I
Anticonvulsants Part IAnticonvulsants Part I
Anticonvulsants Part I
 
Agents for Brain Injury
Agents for Brain InjuryAgents for Brain Injury
Agents for Brain Injury
 
ADHD Drugs
ADHD DrugsADHD Drugs
ADHD Drugs
 
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg SyndromePathophysiology: Myasthenia Gravis & Restless Leg Syndrome
Pathophysiology: Myasthenia Gravis & Restless Leg Syndrome
 

Dernier

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsMebane Rash
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxRamakrishna Reddy Bijjam
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdfssuserdda66b
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsKarakKing
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...pradhanghanshyam7136
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structuredhanjurrannsibayan2
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024Elizabeth Walsh
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - Englishneillewis46
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.MaryamAhmad92
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17Celine George
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxJisc
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxVishalSingh1417
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxVishalSingh1417
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxheathfieldcps1
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseAnaAcapella
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Jisc
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxAmanpreet Kaur
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...Nguyen Thanh Tu Collection
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.pptRamjanShidvankar
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxVishalSingh1417
 

Dernier (20)

On National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan FellowsOn National Teacher Day, meet the 2024-25 Kenan Fellows
On National Teacher Day, meet the 2024-25 Kenan Fellows
 
Python Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docxPython Notes for mca i year students osmania university.docx
Python Notes for mca i year students osmania university.docx
 
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdfVishram Singh - Textbook of Anatomy  Upper Limb and Thorax.. Volume 1 (1).pdf
Vishram Singh - Textbook of Anatomy Upper Limb and Thorax.. Volume 1 (1).pdf
 
Salient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functionsSalient Features of India constitution especially power and functions
Salient Features of India constitution especially power and functions
 
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...Kodo Millet  PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
Kodo Millet PPT made by Ghanshyam bairwa college of Agriculture kumher bhara...
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024FSB Advising Checklist - Orientation 2024
FSB Advising Checklist - Orientation 2024
 
Graduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - EnglishGraduate Outcomes Presentation Slides - English
Graduate Outcomes Presentation Slides - English
 
ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.ICT role in 21st century education and it's challenges.
ICT role in 21st century education and it's challenges.
 
How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17How to Create and Manage Wizard in Odoo 17
How to Create and Manage Wizard in Odoo 17
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Unit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptxUnit-V; Pricing (Pharma Marketing Management).pptx
Unit-V; Pricing (Pharma Marketing Management).pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)Accessible Digital Futures project (20/03/2024)
Accessible Digital Futures project (20/03/2024)
 
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
TỔNG ÔN TẬP THI VÀO LỚP 10 MÔN TIẾNG ANH NĂM HỌC 2023 - 2024 CÓ ĐÁP ÁN (NGỮ Â...
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Unit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptxUnit-IV- Pharma. Marketing Channels.pptx
Unit-IV- Pharma. Marketing Channels.pptx
 

Neuropharmacology: Acetylcholine & Alzheimer's

  • 1. Neurochemistry III: Acetylcholine Brian J. Piper, Ph.D.
  • 2. Objectives • Synthesis • Breakdown • Receptors – nACh – M1 to M5 • Neuroanatomy • Alzheimer’s Disease
  • 3. History 1875-1968 • Sir Henry Dale (Dale’s law) describes 1873-1961 neuron communication as chemical involving Acectylcholine (ACh) in 1914 • Otto Loewi discovers ACh can inhibit the rate of heartbeat in frogs • Nobel Prize 1936
  • 4. 6.1 Synthesis of acetylcholine (ACh) by choline acetyltransferase • Choline: essential nutrient • Acetyl-CoA: acetyl co-enzyme A • ChAT: choline acetyl (COCH3) transferase http://lpi.oregonstate.edu/infocenter/othernuts/choline/
  • 5. Synthesis of acetylcholine (ACh) by choline acetyltransferase • Choline: essential nutrient • Acetyl-CoA: acetyl co-enzyme A • ChAT: choline acetyl (COCH3) transferase http://lpi.oregonstate.edu/infocenter/othernuts/choline/
  • 6. Choline During Development • Choline supplementation shows preclinical benefits against age related cognitive decline and against FAS. • Are there emotional benefits (open-field & FST) Glenn et al. (2012) Brain Research
  • 7. Acetylcholine Production • VAChT: vesicular Acetylcholine transporter packages ACh • Vesamicol: research drug that blocks VAChT Stahl (2001). p. 468
  • 8. Acetylcholine Inactivation • AChE: acetylcholinesterase, breaks down Ach • ChT: Choline Transporter, recycles choline into presynaptic terminal Stahl (2001). p. 469.
  • 9. 6.9 Structure of the nicotinic ACh receptor • Ionotropic • Requires 2 ACh • Activated by nicotine • Blocked by curare
  • 10. 6.4 Myasthenia gravis, an autoimmune disorder Prevalence: 10/million Tx: AChE inhibitors, Upto 1:30: http://www.youtube.com/watch?v=XdpW5RMp-T0&feature=related
  • 11. Muscarinic Acetylcholine Receptors • Metabotropic • M1, M2, M3, M4, M5 Amanita muscaria • Trace amounts of muscarine isolated from Amanita muscaria in 1869 • Found in brain & heart • Antagonist: Atropa Belladonna Inocybe rimosa (atropine)
  • 14. 6.7 Anatomy of cholinergic pathways in the brain • Nucleas basilis: connections to forebrain, important for cognition • Caudate-Putamen: important for motor function
  • 15. Lesson from Lesion Studies • 192 IgG-Saporin: destroys ACh neurons • Functional Deficits not shown until >70% depletions
  • 16. 6.6 Cholinergic synapses in the parasympathetic and sympathetic branches of the ANS
  • 17. Botulism • Infection causes reduced ACh and release • Infants are particularly susceptible
  • 18. Botulinum Toxin A • Botox is FDA approved for cosmetic purposes • Also used for excessive sweating
  • 20.
  • 21. Aloysius ”Alois” Alzheimer • German psychiatrist • Described symptoms + pathology 1864-1913 – Neuronal loss – Plaques – Tangles • Presentation to SW German Psychiatrist meeting ignored but Emil Kraeplin Cipriani et al. (2011) Neurological Sciences, 32(2), 275-279. Auguste Deter, 1851-1906
  • 22. 1st, but possibly, atypical case
  • 23. Healthy Alzheimer’s Disease
  • 25. AD, coronal cross section
  • 26. Amyloid Plaque • Amyloid Beta Peptide: 40/42 amino acids • Amyloid Plaque: clusters of Beta amyloid + • Neurofibrillary tangles
  • 27. Test of Neurocognitive Function • Mini-Mental Status Exam (MMSE) – Where are we in? – Count backwards by 7 starting with 100. – Remember 3 words. • Spatial Learning & Memory • Executive function Folstein, Folstein, & McHugh (1975). J Psychiatric Research, 12, 189-198.
  • 28. Alzheimer’s Vaccine? • Immunization against AB42 produced antibodies • Brain versus Behavior Holmes et al. (2008) Lancet, 372, 216-223.
  • 29. Executive Function Test: Trail Making Test: Part A
  • 31. Executive Function Test 2: Tower of London
  • 32. Tower of London: Difficult Trial
  • 33. Genetic Risk Factors • Apolipoprotein E: Isoform 112 158 – Chromosome 19 E2 Cysteine Cysteine – 299 amino acids – E3 > E2 > E4 E3 Cysteine Arginine E4 Agrinine Agrinine
  • 34. ApoE & Alzheimer’s Disease Corder et al. (1993). Science, 261, 921-3.
  • 35. Hippocampus, CA1, tau IHC Higher magnification
  • 36.
  • 37. Current Alzheimer’s Treatments • Alzheimer’s does involve neurodegeneration of cholinergic neurons • Acetylcholinesterase inhibitors (tacrine) have resulted in only modest/brief benefits
  • 38. Summary Acetylcholine Synthetic Enzymes Inactivating Enzymes Vesicular Transporter Membrane Transporter Where in brain (somas)? Ionotropic Receptor(s) Metabotropic Receptor(s) Agonist(s) Antagonist(s) Disease(s)
  • 39. Self-Test Acetylcholine Synthetic Enzymes Choline Acetyltransferase Inactivating Enzymes Acetylcholinesterase Vesicular Transporter VAChT Membrane Transporter Choline Transporter Where in brain (somas)? Nucleus basilis, striatum Ionotropic Receptor(s) nACh Metabotropic Receptor(s) M1 – M5 Agonist(s) Nicotine, Muscarine Antagonist(s) Atropine Disease(s) Myasthenia Gravis, Alzheimer’s?

Notes de l'éditeur

  1. mq-fig-06-01-0.jpg
  2. mq-fig-06-01-0.jpg
  3. mq-fig-06-09-0.jpg
  4. mq-fig-06-04-0.jpg
  5. mq-fig-06-07-0.jpg
  6. mq-fig-06-06-0.jpg
  7. mq-fig-06-02-0.jpg
  8. mq-table-06-01-0.jpg